Your browser doesn't support javascript.
loading
Impact of CYP2D6, CYP3A5, and ABCB1 Polymorphisms on Plasma Concentrations of Donepezil and Its Metabolite in Patients With Alzheimer Disease.
Kagawa, Yoshiyuki; Yamamoto, Yoshiaki; Ueno, Ayami; Maeda, Toshio; Obi, Tomokazu.
Afiliação
  • Kagawa Y; Laboratory of Clinical Pharmaceutics, School of Pharmaceutical Sciences, University of Shizuoka; and.
  • Yamamoto Y; Laboratory of Clinical Pharmaceutics, School of Pharmaceutical Sciences, University of Shizuoka; and.
  • Ueno A; Department of Clinical Research, National Epilepsy Center, Shizuoka Institute of Epilepsy and Neurological Disorders, Shizuoka City, Japan.
  • Maeda T; Laboratory of Clinical Pharmaceutics, School of Pharmaceutical Sciences, University of Shizuoka; and.
  • Obi T; Laboratory of Clinical Pharmaceutics, School of Pharmaceutical Sciences, University of Shizuoka; and.
Ther Drug Monit ; 43(3): 429-435, 2021 06 01.
Article em En | MEDLINE | ID: mdl-33065613
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Citocromo P-450 CYP2D6 / Subfamília B de Transportador de Cassetes de Ligação de ATP / Doença de Alzheimer / Donepezila Limite: Humans Idioma: En Revista: Ther Drug Monit Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Citocromo P-450 CYP2D6 / Subfamília B de Transportador de Cassetes de Ligação de ATP / Doença de Alzheimer / Donepezila Limite: Humans Idioma: En Revista: Ther Drug Monit Ano de publicação: 2021 Tipo de documento: Article